ATE383863T1 - Kombinationschemotherapie - Google Patents

Kombinationschemotherapie

Info

Publication number
ATE383863T1
ATE383863T1 AT01916350T AT01916350T ATE383863T1 AT E383863 T1 ATE383863 T1 AT E383863T1 AT 01916350 T AT01916350 T AT 01916350T AT 01916350 T AT01916350 T AT 01916350T AT E383863 T1 ATE383863 T1 AT E383863T1
Authority
AT
Austria
Prior art keywords
vitamin
derivative
administering
patient
cell
Prior art date
Application number
AT01916350T
Other languages
English (en)
Inventor
Candace Johnson
Donald Trump
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27392114&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE383863(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/544,724 external-priority patent/US6559139B1/en
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of ATE383863T1 publication Critical patent/ATE383863T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01916350T 2000-03-02 2001-03-02 Kombinationschemotherapie ATE383863T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18650600P 2000-03-02 2000-03-02
US18780600P 2000-03-08 2000-03-08
US09/544,724 US6559139B1 (en) 1997-08-29 2000-04-06 Combination chemotherapy

Publications (1)

Publication Number Publication Date
ATE383863T1 true ATE383863T1 (de) 2008-02-15

Family

ID=27392114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01916350T ATE383863T1 (de) 2000-03-02 2001-03-02 Kombinationschemotherapie

Country Status (8)

Country Link
EP (1) EP1276482B1 (de)
JP (1) JP2003525254A (de)
AT (1) ATE383863T1 (de)
AU (4) AU4338501A (de)
CA (1) CA2401304A1 (de)
DK (1) DK1276482T3 (de)
ES (1) ES2300323T3 (de)
WO (1) WO2001064251A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6521608B1 (en) 1998-03-27 2003-02-18 Oregon Health & Science University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
CA2472578A1 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
US20050043233A1 (en) * 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
CA2661546A1 (en) * 2006-08-25 2008-02-28 Cougar Biotechnology, Inc. Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
AU2007287098C1 (en) * 2006-08-25 2018-03-15 Janssen Pharmaceutica Nv Methods and compositions for treating cancer
EA201691980A1 (ru) * 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
JP2019522032A (ja) 2016-07-29 2019-08-08 ヤンセン ファーマシューティカ エヌ．ベー． 前立腺癌の治療方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US6521608B1 (en) * 1998-03-27 2003-02-18 Oregon Health & Science University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders

Also Published As

Publication number Publication date
ES2300323T3 (es) 2008-06-16
EP1276482A2 (de) 2003-01-22
AU2007200423A1 (en) 2007-02-22
AU2010200000A1 (en) 2010-01-28
WO2001064251A2 (en) 2001-09-07
AU4338501A (en) 2001-09-12
CA2401304A1 (en) 2001-09-07
WO2001064251A3 (en) 2002-05-10
DK1276482T3 (da) 2008-05-26
EP1276482B1 (de) 2008-01-16
AU2007200423B2 (en) 2009-10-01
AU2001243385B2 (en) 2006-11-02
JP2003525254A (ja) 2003-08-26

Similar Documents

Publication Publication Date Title
BR0209147A (pt) Terapia combinada que usa anticorpos anti-egfr e agentes anti-hormonais
NZ336511A (en) Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
DE60026538D1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
DK1030670T3 (da) Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler
EA200001043A3 (ru) Соединения для лечения женской сексуальной дисфункции
TW200500355A (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
DK1276482T3 (da) Kombinationskemoterapi
WO2005117542A3 (en) Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
DE60112102D1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
BRPI0413410A (pt) co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer
AU2003244762A1 (en) Methods and compositions for intravesical therapy of bladder cancer
DE59911734D1 (de) Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
AU2001272017A1 (en) Targeted combination immunotherapy of cancer and infectious diseases
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
CY1107256T1 (el) Χημειοθεραπεια συνδυασμου
MXPA03006359A (es) Metodo para tratamiento del cancer.
EP1547596A4 (de) Medizinische zusammensetzung und verfahren zur behandlung von malignen tumoren und verwendung derselben
UA51221A (uk) Спосіб лікування рецидивів раку шийки матки
MXPA05008879A (es) Una terapia combinada que comprende un derivado de indolopirrolocarbazol y otro agente antitumoral.
JPS62242671A (ja) 癌の治療薬

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1276482

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked